On June 24, an announcement was released via PRNewswire that Syneron and Viora announced a settlement agreement of business and patent litigations. As part of the agreement, Viora iora acknowledged that its Reaction product infringes Syneron's U.S. patent No. 6,662,054 and agreed to pay royalties of 7.5% to 15% for 12 years, depending on the number of relevant systems sold by Viora in the U.S. For details...

In an earlier announcement released via PRNewswire, Syneron Medical reported revenue of $63.4 for Q1 2015, which was an increase of 12% over the previous year and 17% in constant currency. For details...